These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1679255)

  • 1. Neuroleptics and the natural course of schizophrenia.
    Wyatt RJ
    Schizophr Bull; 1991; 17(2):325-51. PubMed ID: 1679255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation trial on the efficacy of neuroleptics on the outcome of schizophrenia].
    Dollfus S; Petit M
    Encephale; 1991; 17(4):247-53. PubMed ID: 1683625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenics fully remitted on neuroleptics for 3-5 years--to stop or continue drugs?
    Cheung HK
    Br J Psychiatry; 1981 Jun; 138():490-4. PubMed ID: 6117347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of the deficit form in refractory schizophrenia].
    Samuelian JC
    Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How high is the relapse rate in schizophrenia?
    Johnstone EC; Geddes J
    Acta Psychiatr Scand Suppl; 1994; 382():6-10. PubMed ID: 7916528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
    Meltzer HY; Sommers AA; Luchins DJ
    J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of long-term schizophrenia by somato-therapeutic measures].
    Gross G; Huber G; Schüttler R
    Psychiatr Clin (Basel); 1980; 13(3-4):179-92. PubMed ID: 6113621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Discontinuation of neuroleptics in chronic schizophrenics. I. Summary of the literature].
    Woggon B
    Int Pharmacopsychiatry; 1979; 14(1):34-56. PubMed ID: 39040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptics, dopamine, and schizophrenia.
    Pickar D
    Psychiatr Clin North Am; 1986 Mar; 9(1):35-48. PubMed ID: 2870480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
    Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
    Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of long-acting neuroleptics in the treatment of schizophrenia].
    Levine J; Schooler NR; Cassano G
    Encephale; 1979; 5(3):285-90. PubMed ID: 39740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of the early response of psychiatric patients to neuroleptics for the subsequent course of treatment].
    Möller HJ; Kissling W; von Zerssen D
    Pharmacopsychiatria; 1983 Mar; 16(2):46-9. PubMed ID: 6135230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine versus typical neuroleptic medication for schizophrenia.
    Wahlbeck K; Cheine M; Essali MA
    Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of antipsychotic effects of neuroleptic drugs.
    Keck PE; Cohen BM; Baldessarini RJ; McElroy SL
    Am J Psychiatry; 1989 Oct; 146(10):1289-92. PubMed ID: 2571305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients.
    Cassens G; Inglis AK; Appelbaum PS; Gutheil TG
    Schizophr Bull; 1990; 16(3):477-99. PubMed ID: 1981108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of neuroleptics in a attempt at understanding the vulnerability to schizophrenia].
    Meurice E
    Acta Psychiatr Belg; 1992; 92(6):339-54. PubMed ID: 1364282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are we using excessive neuroleptics? An argument for systematic neuroleptic dose reduction in stable patients with schizophrenia with specific reference to clozapine.
    Yamin S; Vaddadi K
    Int Rev Psychiatry; 2010; 22(2):138-47. PubMed ID: 20504054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.